CRISPR Therapeutics AG
CRSP- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001674416
In the last 90 days, CRISPR Therapeutics AG insiders filed 0 open-market purchases and 2 sales; 525 institutions reported holding it in 13F filings for Q2 2026, worth $4.16B in total; ARK Invest is the only superinvestor holding it.
Superinvestors holding CRSP, Q2 2026
1 superinvestor reports holding CRISPR Therapeutics AG on Form 13F, worth $516.0M in total. Weight is CRISPR Therapeutics AG's share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| ARK InvestCathie Wood | 3.4% | 9,460,939 | $516.0M | Reduced−16.4% |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of CRSP each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2026
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−16.4%)
Q1 2026
1 superinvestor holding at quarter end
- Added
- ARK Invest (+7.5%)
Q4 2025
1 superinvestor holding at quarter end
- Added
- ARK Invest (+7.5%)
Q3 2025
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−3.9%)
Q2 2025
1 superinvestor holding at quarter end
- Added
- ARK Invest (+0.2%)
Q1 2025
1 superinvestor holding at quarter end
- Added
- ARK Invest (+13.3%)
Q4 2024
1 superinvestor holding at quarter end
- Added
- ARK Invest (+19.7%)
Q3 2024
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−3.6%)
Q2 2024
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−4.6%)
Q1 2024
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−4.4%)
Q4 2023
1 superinvestor holding at quarter end
- Added
- ARK Invest (+19.2%)
Q3 2023
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−2.4%)
Q2 2023
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−8.2%)
Q1 2023
1 superinvestor holding at quarter end
- Added
- ARK Invest (+2.0%)
Q4 2022
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−4.9%)
Q3 2022
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−15.3%)
Q2 2022
1 superinvestor holding at quarter end
- Added
- ARK Invest (+3.4%)
Q1 2022
1 superinvestor holding at quarter end
- Added
- ARK Invest (+3.5%)
Q4 2021
1 superinvestor holding at quarter end
- Added
- ARK Invest (+19.8%)
Q3 2021
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−2.4%)
Q2 2021
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−6.2%)